Literature DB >> 25316742

Safety of tacrolimus in pregnancy.

Will Nevers, Anna Pupco, Gideon Koren, Pina Bozzo.   

Abstract

QUESTION: I have a 30-year-old patient who had a kidney transplant 2 years ago. She is now planning a pregnancy. She has been treated with tacrolimus since her transplant. Will it be safe for the fetus if she continues to take it during the pregnancy or should she switch to a different antirejection medication? ANSWER: If your patient is stable while taking tacrolimus, there is no reason to switch. The current available information does not suggest that tacrolimus increases the risk of major congenital malformations above the baseline risk in the general population. Premature birth and low birth weight are often reported in this population; however, these effects are frequently reported in pregnant transplant patients treated with other immunosuppressant agents and probably reflect the effects of the maternal condition. As there are some reports of hyperkalemia and renal impairment in infants exposed to tacrolimus in utero, kidney function and electrolytes should be monitored in exposed neonates. Copyright© the College of Family Physicians of Canada.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25316742      PMCID: PMC4196812     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  12 in total

1.  Pregnancy after kidney and kidney-pancreas transplantation under tacrolimus: a single center's experience.

Authors:  Ashokkumar B Jain; Ron Shapiro; Velma P Scantlebury; Santosh Potdar; Mark L Jordan; Jareen Flohr; Amadeo Marcos; John J Fung
Journal:  Transplantation       Date:  2004-03-27       Impact factor: 4.939

2.  Pregnancy outcome after liver transplantation: a single-center experience of 71 pregnancies in 45 recipients.

Authors:  Vimala Christopher; Thawab Al-Chalabi; Paul D Richardson; Paolo Muiesan; Mohammed Rela; Nigel D Heaton; John G O'Grady; Michael A Heneghan
Journal:  Liver Transpl       Date:  2006-07       Impact factor: 5.799

3.  The pregnancy rate and live birth rate in kidney transplant recipients.

Authors:  J S Gill; N Zalunardo; C Rose; M Tonelli
Journal:  Am J Transplant       Date:  2009-05-20       Impact factor: 8.086

4.  Review of the course and outcome of 100 pregnancies in 84 women treated with tacrolimus.

Authors:  A Kainz; I Harabacz; I S Cowlrick; S D Gadgil; D Hagiwara
Journal:  Transplantation       Date:  2000-12-27       Impact factor: 4.939

5.  Pregnancy after liver transplantation under tacrolimus.

Authors:  A Jain; R Venkataramanan; J J Fung; J C Gartner; J Lever; V Balan; V Warty; T E Starzl
Journal:  Transplantation       Date:  1997-08-27       Impact factor: 4.939

6.  Pregnancy outcomes after kidney transplantation-immunosuppressive therapy comparison.

Authors:  Alfredo Perales-Puchalt; Jose Maria Vila Vives; Jorge López Montes; Vicente Jose Diago Almela; Alfredo Perales
Journal:  J Matern Fetal Neonatal Med       Date:  2011-11-25

7.  Outcome of four high-risk pregnancies in female liver transplant recipients on tacrolimus immunosuppression.

Authors:  Z Jabiry-Zieniewicz; P Kamiński; B Pietrzak; A Cyganek; K Bobrowska; J Ziółkowski; U Ołdakowska-Jedynak; K Zieniewicz; L Paczek; I Jankowska; M Wielgoś; M Krawczyk
Journal:  Transplant Proc       Date:  2006 Jan-Feb       Impact factor: 1.066

Review 8.  Interpreting tacrolimus concentrations during pregnancy and postpartum.

Authors:  Mary F Hebert; Songmao Zheng; Karen Hays; Danny D Shen; Connie L Davis; Jason G Umans; Menachem Miodovnik; Kenneth E Thummel; Thomas R Easterling
Journal:  Transplantation       Date:  2013-04-15       Impact factor: 4.939

9.  Tacrolimus placental transfer at delivery and neonatal exposure through breast milk.

Authors:  Songmao Zheng; Thomas R Easterling; Karen Hays; Jason G Umans; Menachem Miodovnik; Shannon Clark; Justina C Calamia; Kenneth E Thummel; Danny D Shen; Connie L Davis; Mary F Hebert
Journal:  Br J Clin Pharmacol       Date:  2013-12       Impact factor: 4.335

10.  Pharmacokinetics of tacrolimus during pregnancy.

Authors:  Songmao Zheng; Thomas R Easterling; Jason G Umans; Menachem Miodovnik; Justina C Calamia; Kenneth E Thummel; Danny D Shen; Connie L Davis; Mary F Hebert
Journal:  Ther Drug Monit       Date:  2012-12       Impact factor: 3.681

View more
  5 in total

Review 1.  Managing IBD Therapies in Pregnancy.

Authors:  Jill K J Gaidos; Sunanda V Kane
Journal:  Curr Treat Options Gastroenterol       Date:  2017-03

Review 2.  Pharmacological Approach to Managing Childhood-Onset Systemic Lupus Erythematosus During Conception, Pregnancy and Breastfeeding.

Authors:  Nicole Bitencourt; Bonnie L Bermas
Journal:  Paediatr Drugs       Date:  2018-12       Impact factor: 3.022

Review 3.  Overview of Physical, Neurocognitive, and Psychosocial Outcomes in Pediatric Intestinal Failure and Transplantation.

Authors:  Charles B Chen; Shreeya Chugh; Masato Fujiki; Kadakkal Radhakrishnan
Journal:  Curr Gastroenterol Rep       Date:  2022-08-30

4.  Tacrolimus in the prevention of adverse pregnancy outcomes and diabetes-associated embryopathies in obese and diabetic mice.

Authors:  Ahmad J H Albaghdadi; Melanie A Hewitt; Samantha M Putos; Michael Wells; Terence R S Ozolinš; Frederick W K Kan
Journal:  J Transl Med       Date:  2017-02-13       Impact factor: 5.531

5.  Pregnancy and Neuromyelitis Optica Spectrum Disorder - Reciprocal Effects and Practical Recommendations: A Systematic Review.

Authors:  Rohan D'Souza; Danielle Wuebbolt; Katarina Andrejevic; Rizwana Ashraf; Vanessa Nguyen; Nusrat Zaffar; Dalia Rotstein; Ahraaz Wyne
Journal:  Front Neurol       Date:  2020-10-16       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.